124 related articles for article (PubMed ID: 12968069)
21. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
Huang CS; Fan YE; Lin CY; Hu ML
J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure.
Chalabi N; Satih S; Delort L; Bignon YJ; Bernard-Gallon DJ
Biochim Biophys Acta; 2007 Feb; 1769(2):124-30. PubMed ID: 17321611
[TBL] [Abstract][Full Text] [Related]
23. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
Clinton SK; Emenhiser C; Schwartz SJ; Bostwick DG; Williams AW; Moore BJ; Erdman JW
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):823-33. PubMed ID: 8896894
[TBL] [Abstract][Full Text] [Related]
24. Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Lin MC; Wang FY; Kuo YH; Tang FY
J Agric Food Chem; 2011 Oct; 59(20):11304-18. PubMed ID: 21923160
[TBL] [Abstract][Full Text] [Related]
25. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells.
Hwang ES; Bowen PE
J Med Food; 2004; 7(3):284-9. PubMed ID: 15383220
[TBL] [Abstract][Full Text] [Related]
26. Effect of lycopene isolated from Chlorella marina on proliferation and apoptosis in human prostate cancer cell line PC-3.
Renju GL; Muraleedhara Kurup G; Bandugula VR
Tumour Biol; 2014 Nov; 35(11):10747-58. PubMed ID: 25073513
[TBL] [Abstract][Full Text] [Related]
27. Serum from rats fed red or yellow tomatoes induces Connexin43 expression independently from lycopene in a prostate cancer cell line.
Gitenay D; Lyan B; Talvas J; Mazur A; Georgé S; Caris-Veyrat C; Rock E
Biochem Biophys Res Commun; 2007 Dec; 364(3):578-82. PubMed ID: 17959141
[TBL] [Abstract][Full Text] [Related]
28. Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells.
Ford NA; Elsen AC; Zuniga K; Lindshield BL; Erdman JW
Nutr Cancer; 2011; 63(2):256-63. PubMed ID: 21207319
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
30. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial β-Carotene 9',10' Oxygenase Modulates Prostate Cancer Growth via NF-κB Inhibition: A Lycopene-Independent Function.
Gong X; Marisiddaiah R; Zaripheh S; Wiener D; Rubin LP
Mol Cancer Res; 2016 Oct; 14(10):966-975. PubMed ID: 27406826
[TBL] [Abstract][Full Text] [Related]
32. Lycopene: a review of its potential as an anticancer agent.
Bhuvaneswari V; Nagini S
Curr Med Chem Anticancer Agents; 2005 Nov; 5(6):627-35. PubMed ID: 16305484
[TBL] [Abstract][Full Text] [Related]
33. Induction of connexin 43 by carotenoids: functional consequences.
Bertram JS
Arch Biochem Biophys; 2004 Oct; 430(1):120-6. PubMed ID: 15325919
[No Abstract] [Full Text] [Related]
34. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells.
Koochekpour S; Sartor O; Hiraiwa M; Lee TJ; Rayford W; Remmel N; Sandhoff K; Minokadeh A; Patten DY
Asian J Androl; 2005 Jun; 7(2):147-58. PubMed ID: 15897971
[TBL] [Abstract][Full Text] [Related]
35. Multitargeted therapy of cancer by lycopene.
van Breemen RB; Pajkovic N
Cancer Lett; 2008 Oct; 269(2):339-51. PubMed ID: 18585855
[TBL] [Abstract][Full Text] [Related]
36. Lycopene inhibits the cell proliferation and invasion of human head and neck squamous cell carcinoma.
Ye M; Wu Q; Zhang M; Huang J
Mol Med Rep; 2016 Oct; 14(4):2953-8. PubMed ID: 27510325
[TBL] [Abstract][Full Text] [Related]
37. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
38. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells.
Pastori M; Pfander H; Boscoboinik D; Azzi A
Biochem Biophys Res Commun; 1998 Sep; 250(3):582-5. PubMed ID: 9784387
[TBL] [Abstract][Full Text] [Related]
39. Lycopene as a Potential Bioactive Compound: Chemistry, Extraction, and Anticancer Prospective.
Khalaf RA; Awad M
Curr Cancer Drug Targets; 2023; 23(8):634-642. PubMed ID: 36718971
[TBL] [Abstract][Full Text] [Related]
40. Lycopene modulates growth and survival associated genes in prostate cancer.
Rafi MM; Kanakasabai S; Reyes MD; Bright JJ
J Nutr Biochem; 2013 Oct; 24(10):1724-34. PubMed ID: 23746934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
